Arena Pharmaceuticals

Arena Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of novel drugs targeting G protein-coupled receptors. Arena's pipeline products are primarily concentrated in the fields of gastrointestinal diseases, dermatological conditions, and cardiovascular diseases. Among these is etrasimod, an oral selective sphingosine-1-phosphate (S1P) receptor modulator used to treat a range of immune-inflammatory conditions, including gastrointestinal and dermatological diseases.